Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 2 5Phase 4 4Phase 3 4Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Breast Neoplasms 1128Carcinoma, Non-Small-Cell Lung 718Neoplasms 545Prostatic Neoplasms 502Colorectal Neoplasms 438Multiple Myeloma 336Lung Neoplasms 309Neoplasm Metastasis 288Leukemia, Myeloid, Acute 263Stomach Neoplasms 248Carcinoma, Hepatocellular 245Ovarian Neoplasms 225Rectal Neoplasms 211Colonic Neoplasms 204Lymphoma, Follicular 200Lymphoma 199Leukemia 190Uterine Cervical Neoplasms 181Head and Neck Neoplasms 174Pancreatic Neoplasms 171Lymphoma, Non-Hodgkin 167Leukemia, Lymphocytic, Chronic, B-Cell 166Lymphoma, Large B-Cell, Diffuse 163Recurrence 161Melanoma 158Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Squamous Cell Carcinoma of Head and Neck 147Pain 141Urinary Bladder Neoplasms 139Brain Neoplasms 133

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Sepsis × Clear all
NCT03683329 2026-02-19

DéPOH

Institut Paoli-Calmettes

Phase 3 Completed
398 enrolled

Neoplasms, Shock, Septic, Sepsis

NCT05443854 2022-07-05

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
340 enrolled
Other hematologic neoplasm

Neoplasms, Shock, Septic, Sepsis, Hematologic Neoplasms

NCT00735813 2012-09-05

Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia

Aarhus University Hospital

Phase 3 Completed
129 enrolled

Infections, Neoplasms, Bacteremia, Sepsis

NCT00001338 2008-03-04

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
65 enrolled
Breast

Breast Neoplasms, Fever, Hematologic Diseases, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡